BDNF and Cognitive impairment: Altogether, these data indicate that our model of systemic inflammation-induced cognitive impairment leads to alterations in neurofilament, PSD-95, and BDNF in the chronic phase (1 month after recovery), suggesting the induction of diffuse axonal damage, postsynaptic degeneration, and impaired neurotrophism.